1. Measure Details
Report on the percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period. This is a reverse measure; the goal is to ensure patients keep their A1c < 9%. Practices should try to lower their percentage for this reverse measure.
2. Measure Parameters:
Numerator: Patients whose most recent HbA1c level (performed during the measurement period) is >9.0%.
Denominator: Patients 18-75 years of age with diabetes with a visit during the measurement period.
3. Elation Workflows
1/ Ensure the patient has a diagnosis of Diabetes (E11.9, etc):
2/ Receive HbA1c Labs from a Lab Vendor electronically through Elation, or manually document a patient’s HbA1c Results:
3/ The HbA1c can be recorded in a structured format by clicking "Actions" then selecting "Add Lab Values for Trending."
4. Measure Information
As the seventh leading cause of death in the U.S., diabetes kills approximately 75,000 people a year. People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney failure, amputation of toes, feet or legs, and premature death. In 2012, diabetes cost the U.S. an estimated $245 billion: $176 billion in direct medical costs and $69 billion in reduced productivity. Reducing A1c blood level results by 1 percentage point (eg, from 8.0 percent to 7.0 percent) helps reduce the risk of microvascular complications (eye, kidney and nerve diseases) by as much as 40 percent.
5. Additional Info/FAQs
Although this measure can be satisfied by manually entering lab results, we recommend getting interfaced lab results, if possible. Electronic lab results directly from the lab will also count towards this measure, limiting the need for additional documentation.